![]() |
|
|
|||||||
|
|
LinkBack | Thread Tools | Display Modes |
|
|||
|
WALTHAM, Mass., June 30 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, forecasts that the breast cancer drug market in Russia will reach $226 million by 2014. Factors promoting the market's growth include steady increases in the incidence of postmenopausal breast cancer cases, a slight shift toward ...
|
| Thread Tools | |
| Display Modes | |
|
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Court Blocks Generic Eli Lilly Bone Drug Until 2014 | cancerfr | Bone Cancer | 0 | 09-02-2010 10:56 PM |
| Medicare Change Priced Cancer Drug Out Of Reach | cancerfr | Pancreatic Cancer | 0 | 08-21-2010 02:37 AM |
| Cancer drug removed from U.S. market | cancerfr | Liver Cancer | 0 | 06-22-2010 06:49 AM |
| FDA: Pfizer To Remove Cancer Drug Mylotarg From US Market | cancerfr | Liver Cancer | 0 | 06-22-2010 06:49 AM |
| Global Melanoma Therapeutics Market to Reach $1.1 Billion by 2015, According to New R | cancerfr | Melanoma | 0 | 04-01-2010 04:05 AM |